We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

257 hedge funds and large institutions have $631M invested in Avanos Medical in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 72 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $510M → $631M (+$121M)

1% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 72

1.1% less ownership

Funds ownership: 97.78% → 96.68% (-1.1%)

6% less funds holding

Funds holding: 274 → 257 (-17)

29% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 42

Holders
257
Holders Change
-17
Holders Change %
-6.2%
% of All Funds
3.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
71
Reduced
72
Closed
42
Calls
$217K
Puts
–
Net Calls
+$217K
Net Calls Change
+$158K

Top Buyers

1
BCM
Boone Capital Management
Georgia
+$16M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$13.1M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$11.6M
4
RA
Royce & Associates
New York
+$6.1M
5
Brown Advisory
Brown Advisory
Maryland
+$3.98M

Top Sellers

1
AC
Armistice Capital
New York
-$16.2M
2
Millennium Management
Millennium Management
New York
-$9.67M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$7.72M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.26M
5
UBS Group
UBS Group
Switzerland
-$3.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$5.33M +$202K +15,016 +4%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$4.27M -$18.2K -1,351 -0.4%
VFT
28
Vanguard Fiduciary Trust
Pennsylvania
$4.24M +$4.08M +302,531 New
Principal Financial Group
29
Principal Financial Group
Iowa
$4.01M -$90.1K -6,684 -2%
Lazard Asset Management
30
Lazard Asset Management
New York
$3.96M +$417K +30,954 +12%
TI
31
Trexquant Investment
Connecticut
$3.89M +$3.35M +248,349 +851%
American Century Companies
32
American Century Companies
Missouri
$3.85M +$2.16M +160,153 +140%
BCM
33
Bridgeway Capital Management
Texas
$3.81M -$529K -39,293 -13%
Allianz Asset Management
34
Allianz Asset Management
Germany
$3.72M +$1.67M +124,203 +88%
JP Morgan Chase
35
JP Morgan Chase
New York
$3.45M -$304K -22,556 -8%
Invesco
36
Invesco
Georgia
$2.96M -$164K -12,198 -5%
UBS AM
37
UBS AM
Illinois
$2.94M +$93K +6,903 +3%
Jane Street
38
Jane Street
New York
$2.79M +$2.42M +179,899 +932%
Franklin Resources
39
Franklin Resources
California
$2.65M +$1.52M +113,137 +149%
MAM
40
Martingale Asset Management
Massachusetts
$2.53M +$302K +22,390 +14%
VA
41
VestGen Advisors
Illinois
$2.5M +$1.36M +101,063 New
EF
42
Empowered Funds
Pennsylvania
$2.45M -$529K -39,293 -18%
SEI Investments
43
SEI Investments
Pennsylvania
$2.35M +$1.24M +92,063 +121%
Public Sector Pension Investment Board (PSP Investments)
44
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.33M +$70.3K +5,219 +3%
QCM
45
Quantinno Capital Management
New York
$2.1M -$768 -57 -0%
KIM
46
Kestrel Investment Management
California
$1.96M -$16.2K -1,200 -0.9%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.92M +$46.5K +3,455 +3%
UBS Group
48
UBS Group
Switzerland
$1.86M -$3.8M -282,372 -68%
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$1.82M -$7.72M -573,322 -82%
VGA
50
Vanguard Global Advisers
Pennsylvania
$1.8M +$1.73M +128,237 New
1
2
3 4 5

AVNS Hedge Fund Activity: Q1 2026 in Review

257 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2026, worth a combined $631M — up 24% from $510M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of AVNS and 30 opened new positions — a net loss of 12 holders — while 72 trimmed existing stakes and 71 added.

The largest buyer was Boone Capital Management, opening a new position worth an estimated $16M. The largest seller was Armistice Capital, cutting an estimated $16.2M.

  • 257 institutional investors held Avanos Medical (AVNS) as of Q1 2026, down from 274 in Q4 2025.
  • Funds reported $631M of Avanos Medical stock for Q1 2026, up 24% quarter-over-quarter.
  • 30 funds opened new Avanos Medical positions in Q1 2026 and 42 closed out, a net change of -12 holders.
  • The largest Avanos Medical buyer in Q1 2026 was Boone Capital Management, an estimated $16M added.
  • The largest Avanos Medical seller in Q1 2026 was Armistice Capital, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2026.